Zobrazeno 1 - 10
of 14
pro vyhledávání: '"J R, Gralow"'
Autor:
M E, Mendoza, A, Capafons, J R, Gralow, K L, Syrjala, J M, Suárez-Rodríguez, J R, Fann, M P, Jensen
Publikováno v:
Psycho-oncology. 26(11)
This study evaluated the efficacy of an intervention combining the Valencia model of waking hypnosis with cognitive-behavioral therapy (VMWH-CBT) in managing cancer-related pain, fatigue, and sleep problems in individuals with active cancer or who we
Autor:
M L, Disis, H, Bernhard, F M, Shiota, S L, Hand, J R, Gralow, E S, Huseby, S, Gillis, M A, Cheever
Publikováno v:
Blood. 88:202-210
The current studies evaluate granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant. An important issue for developing vaccine therapy for human malignancy is identifying adjuvants that can elicit T-cell responses to proteins
Publikováno v:
The Journal of Immunology. 156:3151-3158
HER-2/neu, an overexpressed oncogenic protein, has been proposed as a human cancer vaccine target. HER-2/neu is a "self" protein, however, and methods of vaccine strategies that would be effective in immunizing patients to a "self" tumor Ag have not
Publikováno v:
Cancer. 92(4)
Obesity has been shown to affect breast carcinoma prognosis, with the heaviest women having a higher mortality due to breast carcinoma. Few studies have focused on premenopausal women or the correlation of body mass index (BMI) to tumor characteristi
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 42(4)
[18F]16alpha-fluoroestradiol (FES) is a PET imaging agent useful for the study of estrogen receptors in breast cancer. We estimated the radiation dosimetry for this tracer using data obtained in patient studies.Time-dependent tissue concentrations of
Publikováno v:
Cancer. 85(11)
Mammographic and physical examination assessments of the response of locally advanced breast carcinoma (LABC) to neoadjuvant therapy have been shown to be inaccurate. The authors studied the feasibility and accuracy of [technetium 99m]-sestamibi (MIB
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 156(9)
HER-2/neu, an overexpressed oncogenic protein, has been proposed as a human cancer vaccine target. HER-2/neu is a "self" protein, however, and methods of vaccine strategies that would be effective in immunizing patients to a "self" tumor Ag have not
Publikováno v:
Cancer research. 55(5)
Dendritic antigen-presenting cells are considered to be the most effective stimulators of T cell immunity. The use of dendritic cells has been proposed to generate therapeutic T cell responses to tumor antigens in cancer patients. One limitation is t
Publikováno v:
Ciba Foundation symposium. 187
The study of oncogenic viruses led to the discovery that transforming retroviruses contain oncogenes homologous with and/or derived from cellular proto-oncogenes. In humans malignant transformation is often the result of the activation of proto-oncog
Autor:
F. M. Palmieri, C. Grande, F. Cardoso, C. Eagan, D. S. Blum, M. Nelson, M. C. Kirk, J. R. Gralow
Publikováno v:
Journal of Clinical Oncology. 26:1064-1064
1064 Background: The majority of research in office-based breast cancer communication has focused on the adjuvant setting; however, an unmet need exists for insight into dialogue with metastatic breast cancer (MBC) patients. An observational in-offic